Atlas Trials

The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID

Clinical trial NCT02135289 · COMPLETED

Trial details

NCT number
NCT02135289
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory Bowel DiseaseCrohn DiseaseUlcerative ColitisTuberculosisImmune-mediated Inflammatory Disease
Start date
2012-03-01
Primary completion
2019-07-31
Enrollment
9160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.